Postos
165What is your opinion on $NOVO B (-2%) ?
Will the share price fall further or is now a good time to get in?
My development in this area has been very mixed. After I sold in December $WBA (+3,49%) after a risky purchase - to lower the buy in - with +/- 0, my investment in $AFX (+1,13%) was abruptly terminated, leaving me with a hefty loss, and shortly afterwards I unfortunately also lost my shares in $UNH (+0,8%) but still with a profit of 8%. Today I decided to recoup my losses and sold my $BMY (+1,35%) sold. It was a nice trade, plus the €245 dividend plus the payment on February 3rd. The uncertainty in the sector has become too great for me and I want to watch from the sidelines what the new US government will do. Marty Makary as the planned head of the FDA will certainly not strike as brutally as some fear, but there could be changes and difficulties in the area of approval procedures. This would also affect Bristol, which should and must bring a few good products from its pipeline onto the market in the next few years. The acquisition of Karuma together with the approval of KarXT has provided a brief boost, but is not enough to compensate for the expiry of patent protection for Revlimid, Opdivo and especially Eliquis in the next few years. They account for over USD 12 billion of sales and patent protection expires in the EU in 2026 and in the US in 2028. This does not mean that Eliquis will no longer be sold, but a not insignificant proportion is likely to be lost to generics. In addition, CMS has already negotiated price reductions of 56% for 2026. Coupled with the political uncertainties, I have taken the money with me for the time being and will wait and see. I still have to deal with $NOVO B (-2%) ...., which is currently the biggest loss-maker in my portfolio with a drop of almost 17%.
Please let me know your assessment of the market in this sector.
⬆️⬆️⬆️
- BERENBERG raises the price target for SIEMENS from EUR 215 to EUR 245. Buy. $SIE (+0,62%)
- BERNSTEIN raises the price target for SIEMENS ENERGY from EUR 15 to EUR 22. Underperform. $ENR (-0,94%)
- JPMORGAN PUTS SARTORIUS ON 'POSITIVE CATALYST WATCH' - 'OVERWEIGHT' $SRT (+5,94%)
- GOLDMAN raises the price target for FRAPORT from EUR 87 to EUR 90. Buy. $FRA (+0,87%)
- UBS raises the price target for NORDEA from EUR 145 to EUR 146. Buy. $NDA FI (+2,29%)
- BERNSTEIN raises the target price for SCHNEIDER ELECTRIC from EUR 275 to EUR 280. Outperform. $SU (+1,07%)
- UBS raises the target price for WPP from GBP 6.80 to GBP 7.20. Sell. $WPP (-4,22%)
- BERNSTEIN raises the price target for ALSTOM from EUR 17 to EUR 24. Market-Perform. $ALO (-4,63%)
- STIFEL upgrades HERMES from Hold to Buy and raises target price from EUR 2150 to EUR 2560. $RMS (+1,7%)
- INFINEON +4.2% - 'TOP PICK' OF THE UBS $IFX (+2,14%)
⬇️⬇️⬇️
- RBC downgrades UNILEVER from Sector-Perform to Underperform and lowers target price from GBP 48 to GBP 40. $ULVR (+2,84%)
- BERNSTEIN downgrades ABB from Market-Perform to Underperform and lowers price target from CHF 46 to CHF 45. $ABBN (-0,04%)
- BERNSTEIN downgrades SIGNIFY from Outperform to Market-Perform and lowers price target from EUR 30 to EUR 24. $LIGHT (+2,54%)
- DEUTSCHE BANK RESEARCH lowers the price target for UMICORE from EUR 10.50 to EUR 10. Hold. $UMICY
- DEUTSCHE BANK RESEARCH lowers the price target for DOCMORRIS from CHF 45 to CHF 25. Hold. $DOCM (+1,36%)
- BERENBERG lowers the price target for HORNBACH HOLDING from EUR 100 to EUR 94. Buy. $HBH (+0,42%)
- CITIGROUP downgrades ROLLS-ROYCE from Buy to Neutral. $RR. (+1,76%)
- JEFFERIES lowers the target price for BHP GROUP from GBP 22.50 to GBP 21.50. Hold. $BHP (+1,24%)
- JEFFERIES lowers the price target for GLENCORE from GBP 5.50 to GBP 4.50. Buy. $GLEN (-0,88%)
- JEFFERIES lowers the target price for RIO TINTO from GBP 64 to GBP 60. Buy. $RIO (+0,37%)
- BERENBERG lowers the target price for NOVO NORDISK from DKK 975 to DKK 725. Hold. $NOVO B (-2%)
Sold about half of my position with a 265% profit! The stock is currently too overvalued for me, and Palantir had accounted for around 12% of my portfolio due to the profits - too much!!!
I invested the amount directly in $NOVO B (-2%) directly! I see more opportunities here this year than with $PLTR
But if there is a significant setback, I will buy in again immediately!
Thank you very much for all the good wishes and the first few comments on my project.
The first tranches have fluttered into the portfolio! As already announced, the focus is on high-quality, stable dividend payers.
The following key figures are evaluated
Dividend yield
Dividend continuity
Dividend growth
Quality of the company
You can also see 2 unrated stocks, one is Reality Incom, a REIT and therefore not rated with typical characteristics. Therefore "unrated" for me but a must have in a dividend portfolio.
On the other hand, NOVO, where I am betting on the quality and potential growth of the company, coupled with the current weakness of the share price. I want to take advantage of such (supposed) buying opportunities and give the portfolio a certain growth potential in addition to the dividend.
I did not get any execution on United Health Group and Philip Morris.
On Sunday, I will look at my watchlist again and see which stocks are currently correcting and possibly reaching a support level, or are correcting the last move in the uptrend and have a chance of continuing the trend.
Have a nice weekend. Enjoy your time off and let it rip...
hummel hummel...
$O (-0,13%)
$AWK (+0,6%)
$DHL (+0,75%)
$RIO (+0,37%)
$CVS (+0,09%)
$NOVO B (-2%)
$PEP (-0,36%)
Happy New Year everyone! We are starting the new year with adjustments to the Sina ETF. (The performance here below somehow no longer corresponds to the actual performance, but so be it...) After this post you'll have peace and quiet from my ETF again :D
I sold some stocks and invested the dividends I received last year. That left me with 19 euros in cash, so it's still a 40-share ETF ;)
If this were my only portfolio, I would probably have held more cash and not reinvested directly, as the entry point doesn't always seem optimal. But I also proceeded without regard to entry points.
For the question of how high the profits or losses were, please refer to the portfolio.
Out are:
$STLAM (+1,13%) (loss)
$AFX (+1,13%) (loss)
$MC (+1,15%) (loss)
$OR (-0,56%) (loss)
$7203 (+3,13%) (loss)
$D05 (+3,32%) (Profit)
$RHM (+1,72%) (Profit)
$ENR (-0,94%) (Profit; also dropped from my "real" portfolio)
Partial sale:
$WMT (-0,38%) at 50%
Increased by:
$ASML (-0,64%) Since the position was down over 20%, but I am convinced in the long term
New additions:
$NOVO B (-2%) is not tradable at Trade Republik. Today I tried to create a savings plan for $NOVO B (-2%) in the app today and received the message that this share is not tradable. The message does not appear for the US certificate (ADR). Can anyone explain this to me?
Podcast episode 69 "Buy High. Sell Low."
Subscribe to the podcast to make 2025 good.
00:00:00 Portfolio Max
00:30:00 Portfolio Juri
01:22:00 Portfolio Stephan
Spotify
https://open.spotify.com/episode/21rBlhDGjWHtKgUnAWB1Zj?si=AWdM-sIdReWRfMGyCwt0DA
YouTube
Apple Podcast
$MSFT (-0,74%)
$PLTR (-8,53%)
$MSTR (-9,61%)
$BTC (-1,13%)
$AMD (-0,95%)
$COIN (-0%)
$NOVO B (-2%)
$APP (-7,09%)
$SNOW (-2,05%)
$IWDA (-0,07%)
$BLK
$SOL (-3,44%)
I wish you happy holidays :)
think about $UBER (+0,63%) and $NOVO B (-2%) to include in the portfolio. What is your opinion? Below is my current portfolio. I'm still fairly new and would be grateful for any opinions :)
Principais criadores desta semana
